Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Oxidation and cytotoxicity of 6-OHDA are mediated by reactive intermediates of COX-2 overexpressed in PC12 cells.

Tyurina YY, Kapralov AA, Jiang J, Borisenko GG, Potapovich AI, Sorokin A, Kochanek PM, Graham SH, Schor NF, Kagan VE.

Brain Res. 2006 Jun 6;1093(1):71-82. Epub 2006 May 18.

PMID:
16712820
[PubMed - indexed for MEDLINE]
2.

Arachidonic acid-induced carbon-centered radicals and phospholipid peroxidation in cyclo-oxygenase-2-transfected PC12 cells.

Jiang J, Borisenko GG, Osipov A, Martin I, Chen R, Shvedova AA, Sorokin A, Tyurina YY, Potapovich A, Tyurin VA, Graham SH, Kagan VE.

J Neurochem. 2004 Sep;90(5):1036-49.

PMID:
15312159
[PubMed - indexed for MEDLINE]
3.

Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.

Rodriguez-Blanco J, Martín V, Herrera F, García-Santos G, Antolín I, Rodriguez C.

J Neurochem. 2008 Oct;107(1):127-40. doi: 10.1111/j.1471-4159.2008.05588.x. Epub 2008 Jul 28.

PMID:
18665912
[PubMed - indexed for MEDLINE]
4.
5.

Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine.

Barkats M, Millecamps S, Bilang-Bleuel A, Mallet J.

J Neurochem. 2002 Jul;82(1):101-9.

PMID:
12091470
[PubMed - indexed for MEDLINE]
6.

Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action.

Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y, Niki E.

Free Radic Biol Med. 2007 Mar 1;42(5):675-85. Epub 2006 Dec 14.

PMID:
17291991
[PubMed - indexed for MEDLINE]
7.

The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics.

Choi HY, Song JH, Park DK, Ross GM.

Neurosci Lett. 2000 Dec 22;296(2-3):81-4.

PMID:
11108986
[PubMed - indexed for MEDLINE]
8.

Induced expression of early response genes/oxidative injury in rat pheochromocytoma (PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease.

Seth K, Agrawal AK, Aziz MH, Ahmad A, Shukla Y, Mathur N, Seth PK.

Neurosci Lett. 2002 Sep 13;330(1):89-93.

PMID:
12213641
[PubMed - indexed for MEDLINE]
9.

Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation.

Chae SW, Bang YJ, Kim KM, Lee KY, Kang BY, Kim EM, Inoue H, Hwang O, Choi HJ.

Biochem Biophys Res Commun. 2007 Aug 3;359(3):735-41. Epub 2007 Jun 4.

PMID:
17560944
[PubMed - indexed for MEDLINE]
10.

Neuroprotective effects of chalcones from Myracrodruon urundeuva on 6-hydroxydopamine-induced cytotoxicity in rat mesencephalic cells.

Nobre-Júnior HV, Oliveira RA, Maia FD, Nogueira MA, de Moraes MO, Bandeira MA, Andrade GM, Viana GS.

Neurochem Res. 2009 Jun;34(6):1066-75. doi: 10.1007/s11064-008-9876-5. Epub 2008 Nov 13.

PMID:
19005754
[PubMed - indexed for MEDLINE]
11.

NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells.

Li HY, Zhong YF, Wu SY, Shi N.

Chem Res Toxicol. 2007 Sep;20(9):1242-51. Epub 2007 Aug 4.

PMID:
17676812
[PubMed - indexed for MEDLINE]
12.

6-Hydroxydopamine induces cystatin C-mediated cysteine protease suppression and cathepsin D activation.

Lee DC, Womble TA, Mason CW, Jackson IM, Lamango NS, Severs WB, Palm DE.

Neurochem Int. 2007 Mar;50(4):607-18. Epub 2006 Dec 21.

PMID:
17241700
[PubMed - indexed for MEDLINE]
13.

The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.

Mazzio EA, Reams RR, Soliman KF.

Brain Res. 2004 Apr 9;1004(1-2):29-44.

PMID:
15033417
[PubMed - indexed for MEDLINE]
14.

Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease.

Soto-Otero R, Méndez-Alvarez E, Hermida-Ameijeiras A, Muñoz-Patiño AM, Labandeira-Garcia JL.

J Neurochem. 2000 Apr;74(4):1605-12.

PMID:
10737618
[PubMed - indexed for MEDLINE]
15.

PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.

Carrasco E, Casper D, Werner P.

J Neurosci Res. 2007 Nov 1;85(14):3109-17.

PMID:
17868147
[PubMed - indexed for MEDLINE]
16.

Cyclooxygenase-2 is involved in oxidative damage and alpha-synuclein accumulation in dopaminergic cells.

Chae SW, Kang BY, Hwang O, Choi HJ.

Neurosci Lett. 2008 May 9;436(2):205-9. doi: 10.1016/j.neulet.2008.03.031. Epub 2008 Mar 16.

PMID:
18403118
[PubMed - indexed for MEDLINE]
17.

Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.

Smith MP, Cass WA.

Neuroscience. 2007 Feb 9;144(3):1057-66. Epub 2006 Nov 15.

PMID:
17110046
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.

Linert W, Herlinger E, Jameson RF, Kienzl E, Jellinger K, Youdim MB.

Biochim Biophys Acta. 1996 Aug 23;1316(3):160-8.

PMID:
8781534
[PubMed - indexed for MEDLINE]
19.

Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease.

Méndez-Alvarez E, Soto-Otero R, Hermida-Ameijeiras A, López-Real AM, Labandeira-García JL.

Biochim Biophys Acta. 2002 Mar 16;1586(2):155-68.

PMID:
11959457
[PubMed - indexed for MEDLINE]
Free Article
20.

Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1.

Nunome K, Miyazaki S, Nakano M, Iguchi-Ariga S, Ariga H.

Biol Pharm Bull. 2008 Jul;31(7):1321-6.

PMID:
18591768
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk